SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-12-428745
Filing Date
2012-10-19
Accepted
2012-10-19 16:30:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D AMENDMENT NO. 6 d427119dsc13da.htm SC 13D/A 64524
  Complete submission text file 0001193125-12-428745.txt   66143
Mailing Address 107 NORTH RYDE SYDNEY C3 1670
Business Address 140 WICKS RD NORTH RYDE NEW SOUTH WALES 2113 C3 2113 01161298780088
NOVOGEN LTD (Filed by) CIK: 0001075880 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0630
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Subject) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13D/A | Act: 34 | File No.: 005-79594 | Film No.: 121152683
SIC: 2834 Pharmaceutical Preparations